Prime Therapeutics' Advocate+ Provides Financial Solutions for Specialty Drug Access
Introducing Advocate+: Financial Help for Specialty Medications
Prime Therapeutics has unveiled a groundbreaking specialty pharmacy care solution named Advocate+, aimed at providing members with the necessary support to manage the complexities of obtaining specialty medications. Starting January 1, 2025, this program will be available to members of various health plans, including employer group clients and national accounts.
The Complexity of Specialty Drug Access
Obtaining specialty medications is typically more challenging compared to standard retail drugs. According to Nathan Downhour, Pharm.D., senior vice president at Prime, patients often perceive the process as straightforward, only to find it complicated by utilization management and financial hurdles. Advocate+ is designed to simplify this journey by connecting patients with critical financial assistance options, including manufacturer copay cards and nonprofit foundations.
Addressing Affordability Challenges
With prescription drug affordability being an ongoing concern for many Americans, Advocate+ serves to alleviate some of the financial barriers. A recent KFF survey indicates that 37% of individuals on multiple medications struggle to afford their prescriptions. The Advocate+ program seeks to identify tailored financial options based on each member's specific circumstances, improving overall access to essential medicines.
Leveraging Technology for Better Outcomes
Building upon the Pharmacy Match initiative launched earlier this year, Advocate+ utilizes advanced technology from TailorMed to enhance the financial support experience. This data-driven approach assesses members' eligibility and connects them to over 7,000 assistance programs, all tailored to meet individual needs. By leveraging these resources, Prime Therapeutics enables members to navigate the challenges of specialty medication access with greater ease and financial reassurance.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.